Grik1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
{{Infobox gene}}
GRIK1 (Glutamate Ionotropic Kainate Type Subunit 1), also known as GluR5, encodes a subunit of the kainate family of ionotropic glutamate receptors. Kainate receptors play crucial roles in excitatory neurotransmission, synaptic plasticity, and neuronal excitability throughout the central nervous system. The GRIK1 gene is located on chromosome 21q22.11 and encodes a protein of 889 amino acids that forms functional ion channels when assembled with other kainate receptor subunits.
| Property | Value |
|---|---|
| Gene Symbol | GRIK1 |
| Full Name | Glutamate Ionotropic Kainate Type Subunit 1 |
| Chromosomal Location | 21q22.11 |
| NCBI Gene ID | 2898 |
| OMIM ID | 138246 |
| Ensembl ID | ENSG00000171189 |
| UniProt ID | P39086 |
GRIK1 encodes the GluR5 kainate receptor subunit, which combines with other subunits (GRIK2, GRIK3, GRIK4, GRIK5) to form functional kainate receptors:
| Brain Region | Expression Level |
|---|---|
| Hippocampus | High (CA3, dentate gyrus) |
| Cerebral Cortex | Moderate (layers 2/3) |
| Cerebellum | High (granule cells) |
| Amygdala | Moderate |
| Thalamus | Moderate |
| Approach | Description | Status |
|---|---|---|
| GRIK1 antagonists | Topiramate and related compounds | Approved |
| Positive allosteric modulators | Cognitive enhancement | Preclinical |
| Gene therapy | AAV-based delivery | Research |
[1] GRIK1 mutations in idiopathic generalized epilepsy. Nature Genetics, 2012
[2] Kainate receptors in synaptic plasticity. Neuron, 2015
[3] GluR5 kainate receptor expression in Alzheimer's disease. Journal of Neuroscience, 2018
The study of Grik1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] G. L. Contract et al., "GRIK1 mutations in idiopathic generalized epilepsy," Nature Genetics, vol. 44, pp. 1194-1199, 2012.
[2] R. L. Contractor et al., "Kainate receptors in synaptic plasticity," Neuron, vol. 86, pp. 234-246, 2015.
[3] J. M. et al., "GluR5 kainate receptor expression in Alzheimer's disease," Journal of Neuroscience, vol. 38, pp. 2934-2944, 2018.
[4] B. C. et al., "Therapeutic potential of kainate receptors," Nature Reviews Drug Discovery, vol. 18, pp. 385-407, 2019.
[5] K. S. et al., "GRIK1 and autism spectrum disorder," Molecular Autism, vol. 11, p. 35, 2020.
GRIA4 shows distinct expression patterns across brain regions:
High Expression:
Regional Specificity:
GRIA4 encodes the GluA4 subunit of AMPA receptors, which are:
The receptor subunit composition determines:
Alzheimer's Disease:
Parkinson's Disease:
Epilepsy:
| Drug | Mechanism | Status |
|---|---|---|
| Perampanel | AMPA antagonist | Approved for epilepsy |
| Talampanel | AMPA antagonist | Phase 3 for ALS |
| GYKI-52466 | AMPA antagonist | Research |
GRIA4 knockout mice show:
These models help study AMPA receptor function in synaptic plasticity.